Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 08:45  – Posting: # 20125
Views: 394

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)


Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,400 posts in 4,121 threads, 1,323 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time (Europe/Vienna): 21:13 CEST

Science is the great antidote to the poison
of enthusiasm and superstition.    Adam Smith

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5